DrugPatentWatch Database Preview

Details for Patent: 7,291,324

« Back to Dashboard

Which drugs does patent 7,291,324 protect, and when does it expire?

Patent 7,291,324 protects HALFLYTELY and is included in one NDA.

Summary for Patent: 7,291,324

Title:	Method of bowel cleansing
Abstract:	Stimulant laxative in combination with an osmotic laxative produces safe and effective bowel and colon cleansing with a reduced volume of liquid input. Administering to a patient an oral stimulant laxative, such as bisacodyl, followed, after a biologically determined interval, by a reduced volume of a PEG in water solution cleanses the bowels and colon in preparation for diagnostic colonoscopy, without the profuse uncontrollable diarrhea that typically follows either ingestion of large volume isotonic ravages, or smaller volume hypertonic lavages.
Inventor(s):	Dennett, Jr.; Edmund V. (Walpole, MA), Raleigh, Jr.; Robert M. (Braintree, MA), Cleveland; Mark V B. (Duxbury, MA), Pelham; Russell W. (Duxbury, MA)
Assignee:	Braintree Laboratories Inc. (Braintree, MA)
Application Number:	10/277,620
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 7,291,324

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Braintree	HALFLYTELY	bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL	021551-003	Jul 16, 2010		DISCN	Yes	No						GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS